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Abstract
Purpose Cigarette smoking is the major cause of lar-
yngeal cancer. The time to first cigarette after waking in the
morning is a behavior associated with several dimensions
of nicotine dependence including the dose of smoke
uptake. We hypothesized that a short TTFC increases the
risk of laryngeal cancer.
Methods The analysis was based on data from a hospital-
based case–control study of laryngeal cancer. The current
analysis included only subjects who were ever cigarette
smokers, including 570 cases and 343 controls (832 whites
and 81 blacks). Odds ratios (OR) and 95% confidence
intervals (CI) were calculated using unconditional logistic
regression adjusting for smoking history and other potential
confounders. Incidence data from the Surveillance, Epi-
demiology, and End Results (SEER) Program of the
National Cancer Institute from 1975 to 2006 were analyzed
for trends in laryngeal cancer.
Results There was a dose–response relationship between
TTFC and supraglottic cancer. Compared to subjects who
smoked more than 60 min after waking, the adjusted odds
ratio was 1.51 (95% CI, 0.63–3.61) for 30–60 min and 3.13
(95% CI, 1.56–6.30) for 0–30 min. No association was
observed between TTFC and cancer of the glottis. In blacks,
the TTFC was not associated with the risk of laryngeal
cancer. Trends in SEER rates were similar for cancer of the
glottis and supraglottis, indicating that the site-specific
differences were not affected by unknown confounders.
Conclusion A nicotine dependence behavior that is
associated with cigarette smoke uptake increases the risk of
cancer of the supraglottis larynx, but not glottis larynx.
Keywords Nicotine  Smoking  Addiction 
Larynx cancer
Introduction
Cigarette smoking causes cancers, cardiovascular disease,
and other illnesses in a dose-dependent relationship.
Smoking history is usually quantified by the smokers’ age
at smoking initiation, the frequency and duration of
smoking, and the years since quitting. The effects of
smoking on health outcomes can be detected even in small
studies even though a self-reported smoking behavior like
cigarettes per day is only a proxy measure for the dose of
smoke exposure.
The accuracy of self-reported cigarette frequency as a
measure of smoke uptake can be measured by blood, urine,
or saliva cotinine levels. These levels vary by as much as
20-fold in one-pack-a-day smokers [1]. This variation in
cotinine highlights some potentially important limitations in
cancer risk studies. It indicates that misclassification of
exposure might affect the relative and absolute risk of dis-
ease due to cigarette smoking. Secondly, because smoking
may be indicative of other unhealthy lifestyle factors that
affect disease risk, misclassification of smoking as a con-
founding variable in observational studies may impact the
ability to detect associations with other nonsmoking risk
factors. Thirdly, despite the abundance of evidence that
tobacco smoking is caused by a physiological dependence
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on nicotine, smoking has been traditionally considered a
‘‘lifestyle’’ factor in medical research. However, smokers
are addicted to nicotine, and the degree of nicotine depen-
dence affects smoking behaviors such the frequency of
smoking, ability to quit, and relapse.
There are many dimensions of nicotine dependence
including psychological, physiological, and pharmacologic
properties. Social factors such as shared familial environ-
ments, social support, stress, and perceptions of tobacco
may also affect nicotine dependence behaviors. In addition,
genetic and environmental influences may play a signifi-
cant role in nicotine dependence [2]. In association studies,
it is not meaningful or practical to measure nicotine
dependence symptoms from biological markers or psy-
chometric measures because of the long latency between
exposure and health outcomes, and the need to conduct
such measures under controlled and timed protocols.
One specific measure that is highly correlated with the
variation in cotinine levels in active smokers is the time to
first cigarette after waking (TTFC). Like cigarette fre-
quency, TTFC is one of two items of the Fagerstrom Test
for Nicotine Dependence (FTND) that is quantifiable,
whereas other items of the FTND are subjective indicators
of nicotine cravings [3]. A shorter TTFC is significantly
associated with increased cotinine levels. Two nicotine
dependence phenotypes have been characterized by the
TTFC time interval [1]. The ‘‘low’’ dependent phenotype
are smokers who smoke [30 min after waking and smoke
B20 cigarettes per day. The ‘‘high’’ dependent phenotype
are smokers who smoke B30 min after waking, but in
contrast to the low dependent phenotype, have a wide
range of daily cigarette consumption.
While the time to first cigarette is highly correlated with
cotinine, it is also associated with many other dimensions
of nicotine addiction including smoking amount [3, 4],
inability to quit [4–6], smoking relapse [7], tolerance [8],
and nighttime smoking [9]. It is unknown what accounts
for these associations, but the TTFC is thought to reflect
the intensity of smoking such as the depth and frequency of
puffing. The time to first cigarette is considered a measure
of the intensity of smoking whereas cigarettes per day is a
measure of the frequency of smoking.
Laryngeal cancer is caused primarily by smoking. We
hypothesized that an early TTFC was associated with the
risk of laryngeal cancer and its major subsites the supra-
glottis and glottis.
Materials and methods
The methods for the study were previously described [10].
The study was conducted primarily in large academic
medical centers in the New York Metropolitan area to
study the effects of tobacco exposure and larynx cancer
risk. In brief, all newly diagnosed patients with histologi-
cally confirmed laryngeal cancer were identified from
admission, surgical, and oncology logs on a daily basis.
Patients were eligible if they were identified within one
year of diagnosis, spoke English, and were free of any
mental impairment. Nearly all patients were interviewed
within several days post surgery. A trained interviewer
abstracted information from their medical record, including
the histology report and ICD codes. Eligible patients were
approached and requested to participate by a trained
interviewer with the consent of the treating physician. The
study did not include proxy interviews. After signing an
informed consent that was approved by the ethics com-
mittee of both the hospital and the American Health
Foundation, the interviewer administered a structured
questionnaire that contained detailed questions on lifetime
smoking history, alcohol consumption, occupation, and
sociodemographics. Information on smoking included the
age that a subject started smoking regularly, and for each
brand smoked the frequency and duration of smoking. If a
subject was no longer smoking, the years since quitting was
obtained. Subjects were classified as ever having regularly
smoked cigarettes if they smoked at least 100 cigarettes in
their lifetime [11]. The question ‘‘Approximately how
many minutes after you wake (woke) up do(did) you have
your first cigarette?’’ was asked of all subjects. Subjects
were given the following categories of responses: 1–30
min, 31–60 min, [1 h (reference category), and ‘‘do not
know.’’ None of the subjects responded as not knowing.
Controls were consented patients admitted to the same
hospital for conditions unrelated to tobacco smoke expo-
sure and frequency matched to cases by sex, age (within
5 years), race, and month of diagnosis. Controls included
subjects with a wide range of conditions such as acute
conditions, fractures and injuries, nonmalignant diagnosis
such as benign prostatic hypertrophy, and cancers not
caused by tobacco including breast and prostate. The study
was conducted between 1977 and 1999, and the response
rates were very high. About 97% of cases and 91% of
controls who were approached agreed to participate [12].
Subjects who declined to participate reported not feeling
well or lack of interest.
SAS (Cary, NC) statistical software was used to analyze
the data. Unconditional logistic regression procedures were
used to derive odds ratios (OR) and 95% confidence
intervals (CI) associated with the TTFC. We fitted models
that adjusted for smoking status (current vs. former), total
years of exposure, and cigarettes per day. A few subjects
reported quitting less than one year prior to the interview
and were classified as current smokers. The following risk
factors were included in the final models: age (B50, 51–60,
61–70, and [70), sex (male vs. female), race (blacks vs.
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whites), education (B12, 12, 13–15, and C16 years), body
mass index (Weight[lbs] 9 703/(height[in.])2), and alcohol
consumption. These factors have been previously estab-
lished to affect the risk of laryngeal cancer or are associ-
ated with the incidence rates of laryngeal cancer [13, 14].
For alcohol consumption, we determined the total number
of alcohol drinks consumed on a weekly basis, including
12-oz. bottle or cans of beer, glasses of wine, and shots of
hard liquor. About 1/4th of subjects were nondrinkers or
light drinkers (less than one drink per week). Alcohol
consumption was classified as a binary variable, comparing
the upper three quartiles of consumption to the lower
quartile. Site-specific models were developed by compar-
ing cases with supraglottis cancer and glottis cancer to the
entire control series. For all the analyses, statistical sig-
nificance was set at p\0.05, and all tests were two-sided.
A goodness-of-fit test for every model was performed using
the Hosmer and Lemeshow chi-square statistic [15].
The current analysis included subjects who had a
smoking history of at least one cigarette per day for one or
more years. Excluded were never-smokers or smokers who
smoked only cigars or pipes since the question ‘‘Approxi-
mately how many minutes after you wake (woke) up
do(did) you have your first cigarette?’’ did not apply to
them. There were 248 controls who were excluded, of
which 61% were men. Ninety-three percent of excluded
controls were white. There were a wide range of control
diagnoses, and there were little differences in the types of
control diagnoses that were included versus excluded. In
contrast, only 88 cases never smoked cigarettes regularly
and were excluded from the current study. Of these, 59%
were men and 90% were white. The final dataset included
570 cases and 343 controls. Laryngeal cancer cases
included 247 glottis (International Classification of Dis-
eases (ICD-IX): 161.0), 266 cases of supraglottis (ICD-IX:
161.1), and 57 unspecified cases (ICD-IX: 161.9).
SEER*Stat version 6.5.2 software was used to analyze
trends in laryngeal cancer rates in the Surveillance, Epi-
demiology, and End Results registry (SEER) [16]. Age-
adjusted incidence rates per 100,000 persons were calcu-
lated according to the US standard population for the year
2000. The annual percent change (APC) was calculated
from 1975 to 2006. Joinpoint Regression Program was used
to determine inflection points in trends based on significant
changes in the APC for glottis and supraglottic cancer.
Results
Table 1 shows the basic characteristics of the study sub-
jects. Controls were more likely to be never-smokers and
excluded from the current analysis of ever-smokers,
resulting in a larger number of cases than controls for the
current analysis. The mean age was about 59 in both cases
and controls. Seventy-eight percent of both cases and
controls were men, and over 90% of both cases and con-
trols were white. Seventy-eight percent of cases and 48%
of controls were current smokers. Eighty-one percent of
cases and 58% of controls reported smoking their first
cigarette within 30 min after waking.
In logistic regression models of laryngeal cancer, the
three smoking terms, smoking status, total years of smok-
ing, and cigarettes per day, were all statistically significant
(p \ 0.01). There was no overall association between the
TTFC and risk of laryngeal cancer. The adjusted odds ratio
was 0.97 (95% CI, 0.55–1.70) for 31–60 min after waking
and 1.39 (95% CI, 0.89–2.15) for 1–30 min after waking
(Table 2). There was no association with alcohol con-
sumption when comparing the upper quartile with the
lower 3 quartiles (OR = 1.0; 95% CI, 0.9–1.0). Interaction
terms were fitted between total years of smoking and
TTFC, and total years of smoking and alcohol consump-
tion. No significant interactive effects were found.
A significant association was found between TTFC and
cancer of the supraglottis. The OR was 1.51 (95% CI,
0.63–3.61) for 31–60 min and 3.13 (95% CI, 1.56–6.3) for
1–30 min. All three smoking terms were statistically sig-
nificant. A significant inverse association was observed
with body mass index. The OR for alcohol consumption
was 1.0 (95% CI, 1.0–1.0). Interaction terms for smoking







Mean age 58.7 (SD: 8.5) 58.8 (SD: 8.6)
Sex
Men 442 (77.5%) 269 (78.4%)
Women 128 (22.5%) 74 (21.6%)
Race
White 514 (90.2%) 318 (92.7%)
Black 56 (9.8%) 25 (7.3%)
Smoking status
Current 445 (78.1%) 164 (47.8%)
Former 125 (21.9%) 179 (52.2%)
Alcohol consumption
Q1–3 134 (23.5%) 85 (24.8%)
Q4 436 (76.5%) 258 (75.2%)
Time to first cigarette
[60 min 59 (10.4%) 93 (27.1%)
31–60 min 50 (8.8%) 50 (14.6%)
1–30 min 461 (80.8%) 200 (58.3%)
Q quartile
Cancer Causes Control (2012) 23:497–503 499
123
and TTFC, and total years of smoking and alcohol con-
sumption were not significant.
In logistic models of glottis cancer, no significant
association was found for a TTFC of either 31–60 or 1–30
min. There were no significant interactions between
smoking and TTFC and alcohol. Body mass index was not
significantly associated with the risk. The association
between TTFC and unspecified laryngeal cancers was 0.52
(95% CI, 0.05–6.12) for 31–60 min and 3.41 (95% CI,
0.64–18.2) for 1–30 min.
In an analysis limited to white subjects, the findings for
laryngeal cancer, supraglottis cancer only, and glottis
cancer only, the findings were very similar to that for all
subjects. The odds ratios associated with TTFC are shown
in Table 2. The only differences in the analysis restricted to
whites versus all subjects was that while total years of
smoking and cigarettes per day were significantly associ-
ated with cancer of the glottis, cigarette status was not a
significant predictor (p = 0.22).
In black subjects, none of the smoking terms including
the TTFC were statistically significant.
SEER rates of supraglottic cancer were approximately
1.5-fold higher than that for glottis cancer since 1975 in
both men and women. Table 3 shows the trends in SEER
data by laryngeal cancer subsite in whites. Annual age-
adjusted rates increased slightly from 1975 to the mid-
1980s, with inflection points found at 1984 for supraglottic
cancer and 1987 for glottis cancer. Rates declined slightly
afterward. There were no significant differences in the
trends in rates between glottis and supraglottic cancer.
Discussion
Cigarette smoking was associated with an increased risk of
laryngeal cancer in white study subjects. The association
with smoking appeared to be greater for supraglottis cancer
since all three smoking terms were statistically significant,
whereas smoking status was not significant for glottis
cancer. Most previous studies that had site-specific smok-
ing information found higher smoking-related risks relative
to never-smokers for supraglottic cancer than for glottis
cancers [17–30]. It remains unknown why there is a dif-
ference in smoking risk by site. The tumor histology of
both subsites is squamous cell carcinoma, but their pro-
genitor cells differ. Supraglottic lesions arise from cylin-
drical and not squamous cells, and the molecular signatures
of the two cancers also varies [31]. Supraglottic tumors are
more clinically aggressive, with greater nodal spread and
poorer survival rates. There may be differences in sus-
ceptibility to tobacco carcinogens between the two sites,
although there is little data on the effects of single nucle-
otide polymorphisms by laryngeal tumor location. Glottis
cancer is more common in the United States than cancer of
the supraglottis. Because we excluded never-smokers from
the current study; the ratio of glottis to supraglottis cancer
was about the same in the current analysis.
There is little data on smoking-specific risks of laryngeal
cancer in blacks. There were too few black subjects to
detect significant associations in ever-smokers in the
Table 2 Odds ratios and 95%
confidence intervals for
laryngeal cancer and time to
first cigarette in ever-smokers
Odds ratios adjusted for age,
sex, race, education, body mass
index, alcohol consumption,
smoking status, years of
smoking, and cigarettes per day
Larynx cancer Glottis cancer Supraglottis cancer
OR 95% CI OR 95% CI OR 95% CI
Time to first cigarette
[60 min 1.0 1.0 1.0
31–60 min 0.97 0.55–1.70 0.80 0.43–1.49 1.51 0.63–3.61
1–30 min 1.39 0.89–2.15 0.77 0.35–1.70 3.13 1.56–6.30
Whites
[60 min 1.0 1.0 1.0
31–60 min 1.11 0.62–1.99 0.73 0.38–1.39 2.07 0.80–5.33
1–30 min 1.43 0.90–2.27 0.80 0.35–1.82 3.43 1.58–7.43
Blacks
[60 min 1.0 1.0 1.0
31–60 min 0.18 0.02–1.67 1.4 0.01–713 0.11 0.01–3.82
1–30 min 1.04 0.21–5.11 – – 0.55 0.04–7.14
Table 3 Trends in age-adjusted SEER incidence rates for cancer of
the glottis and supraglottis, white race, 1975–2006
Year Glottis APC (95% CI) Supraglottis APC
(95% CI)
1975–1987 0.63 (-0.3, 1.5)
1975–1984 3.0 (1.2, 4.8)
1987–2006 -2.72 (-3.1, -2.3)
1984–2006 -1.8 (-2.3, -1.4)
APC annual percent change
500 Cancer Causes Control (2012) 23:497–503
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current study. It is unknown whether the effects of tobacco
smoke are greater for supraglottis than glottis cancer in
black Americans.
One possible explanation that might help explain the
differences in risk between the two sites is how cigarettes
are smoked. The association between nicotine dependence
and cancer risk has not been studied for several methodo-
logic reasons as previously noted. More highly dependent
smokers may have different smoking patterns that are not
captured by traditional questions on smoking habits such as
cigarettes per day or years of smoking. The time to first
cigarette, in addition to smoking frequency, is a measure of
smoking uptake. Two recent studies showed that a shorter
time to first cigarette after waking nearly doubled the
smoking-adjusted risk of lung and oral cancer in ever-
smokers, compared to smokers who waited an hour after
waking [32, 33]. The current study is consistent with these
findings.
There are several potential limitations in the current
study. Smoking habits may change over time or with age,
and likewise a single question on TTFC might not reflect
lifetime patterns. Even if TTFC does not change with time,
misclassification of TTFC due to poor recall could intro-
duce bias. The findings would not appear to be spurious,
however. Since smoking is associated with glottis cancer
but not as strongly as its association with supraglottic
cancer, subjects with glottis cancer can be considered as
positive scientific controls in that it would be expected that
the TTFC is less strongly associated with glottis cancer
risk. Another potential limitation is that the etiology of the
tumors may differ, and the analysis failed to control for
potential unknown confounders. Human papillomavirus
has been detected in laryngeal carcinoma, although infec-
tion rates were relatively low during the time period of this
study (1980–1990) and there is little data to indicate dif-
ferential infection rates by site within the larynx [34]. We
did not have extensive information on diet in these patients.
A low intake of fruits and vegetables is associated with
increased risk [35], but would probably not affect TTFC.
There may be other unknown confounders; however, the
analysis of the SEER incidence rates showed similar
increasing and decreasing time trends for cancer of the
glottis and supraglottis, indicating a similar etiology.
Smoking is the main cause of laryngeal cancer, and the
similar inflection points at about the same time in the mid-
1980s for supraglottis and glottis cancer reflect the decline
in adult smoking prevalence that began in the 1950s.
In considering a possible association between TTFC and
laryngeal cancer risk, the possible confounding effects of
alcohol need to be considered. A few studies have exam-
ined site-specific risks that indicate higher risks of supra-
glottic cancer [36]. The independent effect of alcohol
consumption on the risk of laryngeal cancer is moderate.
Alcohol consumption was not associated with a significant
increased risk of glottis and supraglottis laryngeal cancer in
the Central and Eastern Europe Multicenter Study in an
analysis comparing heavy to light drinkers [37]. We pre-
viously reported a higher alcohol-associated risk with
cancer of the supraglottis than glottis in an analysis that
included nondrinkers [10]. Two other case–control studies
reported higher alcohol-associated risks with supraglottic
than glottis cancer [38, 39], although no pooled analyses
have been conducted yet to determine whether the differ-
ences by subsite are statistically significant. Among known
confounders, a complete exposure assessment was not
available for alcohol consumption. Although current
drinking status and frequency for different alcoholic bev-
erages was collected, we did not have information on
lifetime consumption patterns, including total years of
alcohol consumption. Alcohol and smoking act multipli-
catively to increase the risk of oral cancer in case–control
studies [40]. Since the current data were limited to ever-
smokers who by extension were more likely to have been
ever-drinkers, a significant interactive effect was not
detected. A more refined analysis by type of alcoholic
beverage or different quantitative exposure measurements
for alcohol might have yielded different findings, but it is
unlikely that this would have affected the odds ratios
associated with the TTFC.
Another possible limitation regarding the generaliz-
ability of the findings is the data collection period. Today’s
smokers smoke lower yield cigarettes than in the past, and
the magnitude of the smoking association with larynx
cancer might be different than that in newer studies. This
might indicate that the magnitude of the TTFC association
would differ as well; however, smoking-related risks using
never-smokers as a referent group in this study are quite
similar to the risk estimates in more recent studies [41]. It
is also possible that the association with TTFC was
underestimated by the use of only three categorical mea-
sures of exposure. The relationship between a shorter
TTFC and increased cotinine levels in smokers is linear.
The highest dose exposure category in the current study
was 1–30 min after waking. If the exposure classification
was based on more refined categories, it is possible that
larger effects would have been detected for subjects
reporting a TTFC within 5 or 15 min.
Strengths of the study included the relatively large
sample size, the high response rate, and detailed tobacco
assessment. The findings are likely generalizable to whites,
but the external validity of the findings in blacks is less
certain. This reflects the relatively small number of black
subjects in the study, and that the participating treatment
centers were located primarily in New York County, and
not Brooklyn County or other boroughs in New York that
have a large black population.
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It is uncertain why a shorter TTFC is associated with
increased cotinine levels, but likely reflects differences in
genetic susceptibility to nicotine dependence, behavioral,
and social factors. The TTFC is thought to measure the
‘‘heaviness’’ of smoking although the smoking behavioral
patterns associated with the first cigarette may be more
complex. The TTFC interval might be indicative of
smoking intensity, but the intensity of smoking the first
cigarette also depends on the actual hour of the day when
the cigarette is actually smoked [42]. Together with
behavioral factors that are potentially important, genotypic
and phenotypic characterizations of nicotine dependence
such as the TTFC may help with the development of tai-
lored therapies. The current study also shows that nicotine
dependence, and a specific nicotine dependence behavior,
the TTFC, is a risk factor for cancer. This reconceptualizes
the traditional characterization of smoking as a lifestyle
risk factor for cancer, a concept that was formulated many
decades ago and continues to be used currently [43, 44].
The magnitude of the risk associated with a short TTFC
was similar to that of heavy versus light smokers, under-
scoring the importance of this measure. The current find-
ings are also potentially useful in helping identify and
inform smokers who are at increased risk due to a short
TTFC. The TTFC might be useful in helping develop more
effective or individually tailored smoking cessation efforts.
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